Evaluation of the central pedicled, modified Wise‐pattern technique as a standard level II oncoplastic breast‐conserving surgery: A retrospective clinicopathological study of 190 breast cancer patients

2019 ◽  
Vol 25 (5) ◽  
pp. 922-926 ◽  
Author(s):  
Péter Kelemen ◽  
Dávid Pukancsik ◽  
Mihály Újhelyi ◽  
Eszter Kovács ◽  
Alexia Stamatiou ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Patients ◽  
Breast Conserving Surgery ◽  
Breast Cancer Patients ◽  
Level Ii ◽  
Clinicopathological Study ◽  
Standard Level ◽  
Wise Pattern

scholarly journals Usefulness of 3D-surgical guides in breast conserving surgery after neoadjuvant treatment

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Han Shin Lee ◽  
Hee Jeong Kim ◽  
Il Yong Chung ◽  
Jisun Kim ◽  
Sae Byul Lee ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Patients ◽  
Neoadjuvant Treatment ◽  
Breast Conserving Surgery ◽  
Resection Margins ◽  
Breast Cancer Patients ◽  
Original Tumor ◽  
Surgical Guides ◽  
Neoadjuvant Systemic Therapy ◽  
Tumor Area

AbstractWe used 3D printed-breast surgical guides (3DP-BSG) to designate the original tumor area from the pre-treatment magnetic resonance imaging (MRI) during breast-conserving surgery (BCS) in breast cancer patients who received neoadjuvant systemic therapy (NST). Targeting the original tumor area in such patients using conventional localization techniques is difficult. For precise BCS, a method that marks the tumor area found on MRI directly to the breast is needed. In this prospective study, patients were enrolled for BCS after receiving NST. Partial resection was performed using a prone/supine MRI-based 3DP-BSG. Frozen biopsies were analyzed to confirm clear tumor margins. The tumor characteristics, pathologic results, resection margins, and the distance between the tumor and margin were analyzed. Thirty-nine patients were enrolled with 3DP-BSG for BCS. The median nearest distance between the tumor and the resection margin was 3.9 cm (range 1.2–7.8 cm). Frozen sections showed positive margins in 4/39 (10.3%) patients. Three had invasive cancers, and one had carcinoma in situ; all underwent additional resection. Final pathology revealed clear margins. After 3-year surveillance, 3/39 patients had recurrent breast cancer. With 3DP-BSG for BCS in breast cancer patients receiving NST, the original tumor area can be identified and marked directly on the breast, which is useful for surgery. Trial Registration: Clinical Research Information Service (CRIS) Identifier Number: KCT0002272. First registration number and date: No. 1 (27/04/2016).

scholarly journals 113P Impact of local recurrence on disease-specific survival in breast cancer patients who underwent breast-conserving surgery

2020 ◽  
Vol 31 ◽  
pp. S54
Author(s):  
D.G. Tiezzi ◽  
L. de Mattos ◽  
L.F. Orlandini ◽  
F.J. Candido Dos Reis ◽  
H.H. Carrara ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Local Recurrence ◽  
Cancer Patients ◽  
Breast Conserving Surgery ◽  
Disease Specific Survival ◽  
Breast Cancer Patients ◽  
Disease Specific

Survival disadvantage among Medicaid-insured breast cancer patients treated with breast conserving surgery without radiation therapy

2006 ◽  
Vol 101 (2) ◽  
pp. 207-214 ◽  
Author(s):  
Kristie Long Foley ◽  
Gretchen Kimmick ◽  
Fabian Camacho ◽  
Edward A. Levine ◽  
Rajesh Balkrishnan ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Radiation Therapy ◽  
Cancer Patients ◽  
Breast Conserving Surgery ◽  
Breast Cancer Patients
Sign in / Sign up

Export Citation Format

Share Document